Growth Metrics

Haemonetics (HAE) Net Cash Flow (2016 - 2025)

Haemonetics has reported Net Cash Flow over the past 17 years, most recently at $66.1 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 138.1% year-over-year to $66.1 million; the TTM value through Dec 2025 reached $35.5 million, down 73.29%, while the annual FY2025 figure was $128.6 million, 225.53% up from the prior year.
  • Net Cash Flow for Q4 2025 was $66.1 million at Haemonetics, up from $4.3 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $167.1 million in Q2 2024 and troughed at -$160.0 million in Q4 2023.
  • A 5-year average of $9.1 million and a median of $4.8 million in 2021 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: crashed 635.35% in 2023 and later surged 5077.38% in 2024.
  • Year by year, Net Cash Flow stood at $19.6 million in 2021, then plummeted by 210.9% to -$21.8 million in 2022, then crashed by 635.35% to -$160.0 million in 2023, then surged by 117.35% to $27.8 million in 2024, then skyrocketed by 138.1% to $66.1 million in 2025.
  • Business Quant data shows Net Cash Flow for HAE at $66.1 million in Q4 2025, $4.3 million in Q3 2025, and -$18.0 million in Q2 2025.